Trupanion, INC. Stock: price and insider trades · United States · SEC (Form 4)

About Trupanion, INC.

Trupanion, Inc. (NASDAQ: TRUP) is a specialized pet medical insurance company focused on cats and dogs. It is a United States-based public company listed on the NASDAQ market, founded in 2000 and headquartered in Seattle, Washington, United States. For investors, Trupanion should be viewed as a niche insurance platform operating at the intersection of animal health, claims data, and veterinary services rather than as a broad-based multiline insurer. The company describes itself as a leader in medical insurance for cats and dogs across the United States, Canada, and certain countries in Continental Europe, with more than 1 million pets currently enrolled according to its recent corporate communications. Its model is data-driven and vertically integrated, allowing it to price policies according to each pet’s characteristics and selected coverage level. Trupanion’s flagship offering is a lifetime pet medical insurance product with unlimited payouts on eligible expenses, which is a key differentiator in a market where pet owners are increasingly sensitive to veterinary inflation and rising treatment costs. One of the company’s most distinctive competitive advantages is its patented process that enables direct payment to veterinarians in seconds at checkout, reducing friction for both pet owners and veterinary clinics. This checkout technology helps support Trupanion’s positioning with veterinary partners and strengthens its ecosystem around the point of care. Commercially, the company relies on a mix of direct-to-consumer acquisition, veterinary partnerships, breeder and shelter relationships, affiliate channels, and other distribution initiatives. Recent public disclosures and press releases have highlighted strong growth in specialty veterinary care claims and materially higher average claim amounts in several specialties, underscoring the continuing inflation in animal healthcare costs and the increasing importance of insurance coverage. In 2025 and early 2026, Trupanion continued to emphasize its long-term growth strategy, its recurring-revenue membership base, and its geographic expansion beyond the core U.S. market. For equity investors, TRUP offers exposure to a secular theme: rising pet healthcare adoption and broader insurance penetration in animal health. At the same time, the investment case remains tied to underwriting discipline, claims trends, customer acquisition efficiency, and the company’s ability to maintain pricing power while scaling its membership base.